Please find attached the Company''s clarification to your emailed letter no. L/SURV/ONL/PV/SJ/202-2026-3364 dated 09/February/2026, in respect of significant movement in the price of the Company''s security on the BSE platform, in the recent past.
Clarification On Price Movement - Company Reply
Filed with BSE · · 1 page · English
Release
Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Jan 31 2026
- Announcement under Regulation 30 (LODR)-Investor Presentation
- Sudarshan Pharma Industries Ltd Press Release Jan 30 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Sudarshan Pharma Industries Ltd Press Release Jan 22 2026
Later from Sudarshan Pharma Industries
- Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - GST Inspection, Search And Seizure
- Sudarshan Pharma Industries Ltd Press Release Feb 22 2026
- Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Updates On GST Inspection, Search And Seizure
- Sudarshan Pharma Industries Ltd Press Release Feb 26 2026
- Closure of Trading Window
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries